GGrantIndex
Sort

64,565 grants matching drug discovery

Novel Molecular Therapies of Prostate Cancer

$1,272,322
Dario C. Altieri · Wistar Institute · P01 · FY2016 · CA

Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery

$1,272,115
Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2025 · AI

PARS inhibitor therapy for smoke inhalation

$1,271,724
Inotek Pharmaceuticals Corporation · R44 · FY2003 · HL

SBIR Phase II: In Vitro 3D Tissue Model for Toxicity Screening and Drug Discovery

$1,271,000
Glauco R Souza · Nano3d Biosciences, Inc. · · FY2011 · TIP

Multiomic genomic mapping with long read sequencing

$1,270,748
Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2024 · GM

Entry and replication of positive-sense, RNA viruses

$1,270,265
Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Administrative Core

$1,269,269
William H. McBride · University Of California Los Angeles · U19 · FY2019 · AI

Preclinical drug development in pancreatic cancer

$1,268,802
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Combinatorial Approaches for Novel Anticancer Agents

$1,268,693
University Of Pittsburgh At Pittsburgh · P01 · FY2005 · CA

Regulatory landscape of the human genome: comparative and evolutionary analysis.

$1,267,987
Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2015 · LM

Customized stem cells for clinical application in blood disorders

$1,267,717
George Q Daley · Boston Children'S Hospital · R24 · FY2012 · DK

Procurement and Characterization of Postmortem Brain Tissue

$1,267,539
Joel Kleinman · National Institute Of Mental Health · ZIC · FY2011 · MH

Development of a5* nAChR positive allosteric modulators for tobacco dependence

$1,267,308
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · DA

Contraception by Blockade of Periovulatory Events in Primates

$1,267,089
Richard L Stouffer · Oregon Health & Science University · U54 · FY2010 · HD

Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)

$1,267,025
Timothy I Richardson · Indiana University Indianapolis · U54 · FY2025 · AG

San Antonio Claude D. Pepper Older Americans Independence Center

$1,266,861
Sara Elyse Espinoza · University Of Texas Hlth Science Center · P30 · FY2022 · AG

Design And Development Of Experimental Therapeutics

$1,266,468
Nigel H. Greig · National Institute On Aging · ZIA · FY2014 · AG

Mechanisms of inherited neurodegenerative diseases

$1,266,452
Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS

Identification of novel MDR antimicrobials from human microbiome symbioses

$1,266,106
Nasia Safdar · University Of Wisconsin-Madison · U19 · FY2023 · AI

Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis

$1,265,305
Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2020 · HL

AMP-AD Data Coordination Center

$1,265,279
Lara M Mangravite · Sage Bionetworks · U24 · FY2019 · AG

Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors

$1,265,173
James C Sacchettini · Texas A&M University · U01 · FY2010 · GM

Factors Influencing Genetic Transcription Initiation And Termination

$1,265,140
Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

High Throughput Screening for Ligands for Seven Transmembrane-spanning Receptors

$1,265,078
Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Functional Selectivity: A Novel approach for CNS Drug Discovery

$1,264,814
Bryan L Roth · Univ Of North Carolina Chapel Hill · U19 · FY2008 · MH